☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Avastin
Roche Reports Updated OS Data of Tecentriq + Avastin in P-III IMbrave150 Study for Unresectable HCC
January 12, 2021
Chugai's Tecentriq (atezolizumab) and Avastin (bevacizumab) Receive MHLW's Approval as 1L Treatment for Unresectable Hepatocellula...
September 28, 2020
Top 20 Prescription Drugs Based on 2019 Revenue
July 17, 2020
Insights+ Key Biosimilars Events of August 2019
September 9, 2019
Cipla Signs an Exclusive License Agreement with Bio-Thera for its BAT1706 (bevacizumab- biosimilar)
January 15, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.